PlainPharmaWatch

CMS Open Payments · Tool

Nvision Biomedical Technologies, Inc. vs Acteon Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Nvision Biomedical Technologies, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,290, versus 621 for the other company. Its single largest recorded recipient represents 27.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Nvision Biomedical Technologies, Inc.
HHI 1,290 · top recipient 27.2%
Ranked #925 of 1,838 companies by HHI
Acteon Inc
HHI 621 · top recipient 21.5%
Ranked #1,226 of 1,838 companies by HHI

Payment Overview

Total Payments
$80.7K
% of Industry
0.0%
Transactions
141
Avg per Transaction
$572.02
Recipients
141
Avg per Recipient
$572.02
Payment Types
4
Top Payment Type
Royalty or License
Company B

Acteon Inc

Total Payments
$79.3K
% of Industry
0.0%
Transactions
183
Avg per Transaction
$433.58
Recipients
183
Avg per Recipient
$433.58
Payment Types
5
Top Payment Type
Gift

Highlighted values indicate the higher figure for each metric.

Total payments compared

Nvision Biomedical Technologies, Inc. vs Acteon Inc - total reported payments in CMS Open Payments PY2024

Nvision Biomedical Technolo…$80.7KActeon Inc$79.3K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Nvision Biomedical Technologies, Inc.

Royalty or License $52.8K

65.5%

Consulting Fee $18.0K

22.3%

Travel and Lodging $8.0K

9.9%

Food and Beverage $1.8K

2.3%

Acteon Inc

Gift $60.7K

76.5%

Compensation for Services Other Than Consulting $14.5K

18.3%

Travel and Lodging $1.9K

2.4%

Food and Beverage $1.6K

2.0%

Compensation for Faculty or Speaker (Medical Education) $700.96

0.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Nvision Biomedical Technologies, Inc.

  1. 1

    DAVID YEAGER

    $21,917.56 · 4 txns

  2. 2

    STEPHEN OBRIEN

    $12,106.22 · 28 txns

  3. 3

    MICA MURDOCH

    $7,203.75 · 6 txns

  4. 4

    WALTER STRASH

    $6,047.50 · 6 txns

  5. 5

    CHRISTOPHER HAPP

    $5,235.75 · 2 txns

Acteon Inc

  1. 1

    STEVEN VORHOLT

    $17,083.25 · 7 txns

  2. 2

    CHRISTOPHER PATTERSON

    $6,333.00 · 1 txns

  3. 3

    Toussaint Robeson Crawford

    $3,324.00 · 1 txns

  4. 4

    Nadia Iqbal

    $3,300.00 · 2 txns

  5. 5

    Sanford L Barr

    $2,208.00 · 1 txns

Summary Comparison

Metric Nvision Biomedical Technologies, Inc. Acteon Inc
Total Payments $80.7K $79.3K
% of Industry Total 0.0% 0.0%
Transaction Count 141 183
Avg per Transaction $572.02 $433.58
Recipient Count 141 183
Avg per Recipient $572.02 $433.58
Payment Type Count 4 5
Top Payment Type Royalty or License Gift

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.